Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study

Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) may be curative for colorectal cancer patients with peritoneal metastases (PMs) but it has a high rate of morbidity. Accurate preoperative patient selection is therefore imperative, but is constrained by the limitations...

Full description

Bibliographic Details
Main Authors: Jamie J. Beagan, Nina R. Sluiter, Sander Bach, Paul P. Eijk, Stijn L. Vlek, Daniëlle A. M. Heideman, Miranda Kusters, D. Michiel Pegtel, Geert Kazemier, Nicole C. T. van Grieken, Bauke Ylstra, Jurriaan B. Tuynman
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
circulating tumor DNA
colorectal cancer
peritoneal metastases
CRS-HIPEC
droplet digital PCR
liquid biopsy
Online Access:https://www.mdpi.com/2077-0383/9/6/1738

Internet

https://www.mdpi.com/2077-0383/9/6/1738

Similar Items